Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway
Authors
Keywords
TNBC, PI3K/Akt/mTOR, Anilide (dicarboxylic acid) shikonin esters, Antitumor, 3D-QSAR
Journal
BIOORGANIC CHEMISTRY
Volume 111, Issue -, Pages 104872
Publisher
Elsevier BV
Online
2021-03-30
DOI
10.1016/j.bioorg.2021.104872
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
- (2020) Sadegh Fattahi et al. LIFE SCIENCES
- Shikonin derivatives for cancer prevention and therapy
- (2019) Joelle C. Boulos et al. CANCER LETTERS
- Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR
- (2019) Wen-Xue Sun et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia
- (2018) Yu Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison
- (2018) Salman M. Albeshan et al. Clinical Breast Cancer
- Design and characterization of α -lipoic acyl shikonin ester twin drugs as tubulin and PDK1 dual inhibitors
- (2018) Hong-Yan Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Shikonin exerts antitumor activity in Burkitt’s lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin
- (2018) Fan Ni et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents
- (2018) Yu Ke et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells
- (2018) Pallabita Chowdhury et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Anti-tumor activity of Shikonin against afatinib resistant non-small cell lung cancer via negative regulation of PI3K/Akt signaling pathway
- (2018) Baiying Li et al. BIOSCIENCE REPORTS
- Discovery of (4-bromophenyl)(3-hydroxy-4-methoxyphenyl)methanone through upregulating hTERT induces cell apoptosis and ERS
- (2017) Xiu Cheng et al. Cell Death & Disease
- Shikonin Derivative DMAKO-05 Inhibits Akt Signal Activation and Melanoma Proliferation
- (2016) Yao-yao Yang et al. Chemical Biology & Drug Design
- Fascaplysin Induces Caspase Mediated Crosstalk Between Apoptosis and Autophagy Through the Inhibition of PI3K/AKT/mTOR Signaling Cascade in Human Leukemia HL-60 Cells
- (2015) Suresh Kumar et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Role of PI3K/Akt/mTOR and MEK/ERK pathway in Concanavalin A induced autophagy in HeLa cells
- (2014) Bibhas Roy et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis
- (2014) Amanda Eng et al. PLOS MEDICINE
- Integration of Different “-omics” Technologies Identifies Inhibition of the IGF1R-Akt-mTOR Signaling Cascade Involved in the Cytotoxic Effect of Shikonin against Leukemia Cells
- (2013) Benjamin Wiench et al. Evidence-based Complementary and Alternative Medicine
- Targeting triple-negative breast cancer: optimising therapeutic outcomes
- (2012) K. Gelmon et al. ANNALS OF ONCOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Deciphering the Role of PI3K/Akt/mTOR Pathway in Breast Cancer Biology and Pathogenesis
- (2010) Priscilla F. McAuliffe et al. Clinical Breast Cancer
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- SYUNZ-16, a newly synthesized alkannin derivative, induces tumor cells apoptosis and suppresses tumor growth through inhibition of PKB/AKT kinase activity and blockade of AKT/FOXO signal pathway
- (2009) Rong Deng et al. INTERNATIONAL JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started